0
Es befinden sich keine Waren im Warenkorb !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Start > NY-ESO-1

NY-ESO-1

Brief Information

Name:Cancer/testis antigen 1
Target Synonym:CTAG1A more,Autoimmunogenic cancer/testis antigen NY-ESO-1,LAGE2A,CTAG1,CTAG1A,CTAG1B,Cancer/Testis Antigen 1B,Cancer/Testis Antigen 6.1,L Antigen Family Member 2,Cancer/Testis Antigen 1,LAGE-2,LAGE2B,CT6.1,CTAG,ESO1,Cancer Antigen 3,NY-ESO-1,LAGE2,New York Esophageal Squamous Cell Carcinoma 1
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:16
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

Nach Produktstatus:
Nach Produktkategorie :
Nach Arten:
Nach Markierungen:
Kat. Nr. Arten Produktbeschreibung Struktur Reinheit Merkmal
CHEK-STP114 Human NY-ESO-1 specific TCR-HEK293 cell line
ACRO Quality

Part of Bioactivity data

CHEK-STP114-Cell-based assay
 NY-ESO-1 FACS

FACS analysis NY-ESO-1 specific TCR on NY-ESO-1 specific TCR-HEK293 cell line.
FACS assay shows that PE-Labeled Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQC) Tetramer Protein can bind to NY-ESO-1 specific TCR-HEK293 cell line. NY-ESO-1 specific TCR-HEK293 cell line was red line, Negative control HEK293 cells was grey line (QC tested).

Synonym Name

NY-ESO-1

Background

Clinical and Translational Updates

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland

Nachricht schicken